Supported by

Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

361 results

ANOCA/INOCA: when angiography is not enough to reach a diagnosis

16 May 2024 – From EuroPCR 2024

This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...

ANOCA/INOCA: when angiography is not enough to reach a diagnosis

Management of PCI complications - Part 1

16 May 2024 – From EuroPCR 2024

This session comprises a series of selected EuroPCR 2024 Clinical Case submissions, focusing on the management of various PCI complications. Participants will explore cases involving coronary physiology challenges, iatrogenic compressive coronary intramural hematoma, misbehaving stents, catheter-induced dissections, and device malfunctions, along with the corresponding bailout techniques...

Mastering the Art of Complication Management in PCI

Other coronary interventions: SSO2, angioPy & more

16 May 2024 – From EuroPCR 2024

This session showcases a diverse array of innovative coronary interventions and technologies, including the use of super-saturated oxygen therapy in STEMI, the validation of intracoronary flow velocity measurement, the application of laser and optics-based coronary intravascular lithotripsy, and the development of contrast-free and X-ray-free PCI techniques....

Other coronary interventions: SSO2, angioPy & more

An image is worth a 1,000 words

15 May 2024 – From EuroPCR 2024

An image is worth a 1,000 words

When coronary physiology is crucial

15 May 2024 – From EuroPCR 2024

This session comprises selected EuroPCR 2024 Clinical Case submissions where coronary physiology played a crucial role in the management of complex coronary cases. It will cover topics such as the appropriate use of physiology-guided PCI, the role of ultra-low-contrast PCI, and the management of unstable angina.

When coronary physiology is crucial

PCI in challenging coronary anatomies

15 May 2024 – From EuroPCR 2024

This session explores various complex PCI cases, providing insights and solutions for navigating challenging coronary anatomies. The discussions cover techniques for crossing difficult paths, the role of PCI as a backup for CABG, and the use of specialized tools like balloons and rotablation when standard approaches...

PCI in challenging coronary anatomies

New frontiers in coronary physiology and imaging

15 May 2024 – From EuroPCR 2024

New frontiers in coronary physiology and imaging

Randomised trials: substudies and extended follow-up - A quick update

15 May 2024 – From EuroPCR 2024

This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...

Randomised trials: substudies and extended follow-up - A quick update

Management of patient with coronary artery disease and left ventricle dysfunction

15 May 2024 – From EuroPCR 2024

This session focuses on the management of patients with stable coronary artery disease and left ventricular dysfunction. Experts will discuss the role of mechanical circulatory support devices in these patients, as well as the diagnosis and treatment of microvascular angina, which can be a challenging complication...

Management of patient with coronary artery disease and left ventricle dysfunction

Supraflex Cruz - Improving patient outcomes: from simple to complex patients

14 May 2024 – From EuroPCR 2024

Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients